Skip to Content Facebook Feature Image

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

Business

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing
Business

Business

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

2024-09-09 21:00 Last Updated At:21:15

SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced its collaboration with Roche to integrate Lunit SCOPE PD-L1 22C3 TPS into Roche's navify® Digital Pathology platform. This marks the first deployment of Lunit's AI technology with Roche, supporting pathologists and scientists with enhanced tools for cancer research as part of Roche's initiative to create a collaborative digital pathology ecosystem.

Roche's navify® Digital Pathology is an enterprise software application designed for the pathologist's workflow. It now incorporates a range of AI-driven algorithms, including Lunit SCOPE, creating easy access to external innovation. The integrations aim to offer a comprehensive suite of digital pathology tools that enhance biomarker testing for cancer research and improve patient outcomes through precision medicine.

The collaboration spans significant global territories, starting with the US, with future expansion targeted for Canada, the EU (UK), Korea, and Japan, underscoring the strategic intent to enhance cancer diagnostics and treatment across diverse healthcare markets.

Lunit SCOPE PD-L1 22C3 TPS is an AI-powered tool that provides high-value insights and analysis of the PD-L1 tumor proportion score (TPS), a critical biomarker in cancer immunotherapy. By automating the PD-L1 scoring process, it provides more accurate, consistent, and efficient assessments of PD-L1 TPS scoring, a particularly challenging biomarker.

Lunit SCOPE PD-L1 has been available for research use only since 2021. This new accessibility in the Roche navify platform is designed to maximize access to this leading-edge AI.

"We're thrilled to work together with Roche within its open digital pathology ecosystem, which we believe will create powerful synergies and represent a significant step toward making Lunit's AI tools accessible globally," said Brandon Suh, CEO of Lunit. "Today, we have made PD-L1 analysis available, and we look forward to sharing more of our tools on this platform in the future. By integrating our precise and reliable algorithms, we aim to accelerate the advancement of precision medicine, enhancing workflow efficiency and introducing new biomarkers for improved patient care."

Lunit SCOPE PD-L1 TPS is for research use only, and is not for use in diagnostic procedures.

About Lunit
Founded in 2013, Lunit (KRX:328130.KQ) is a medical AI company on a mission to conquer cancer. We harness AI-powered medical image analytics and AI biomarkers to ensure accurate diagnosis and optimal treatment for each cancer patient. Our FDA-cleared Lunit INSIGHT suite for cancer screening serves over 3,500 hospitals and medical institutions across 50+ countries.

Our clinical studies have been published in top journals, including the Journal of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as the ASCO and RSNA. In 2024, Lunit acquired Volpara Health Technologies, setting the stage for unparalleled synergy and accuracy, particularly in breast health and screening technologies. Headquartered in Seoul, South Korea, with a network of offices worldwide, Lunit leads the global fight against cancer. Discover more at lunit.io.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

Next Article

INSIDE THE DREAM: MUGLER, THE NEW DOCUMENTARY

2024-09-17 01:49 Last Updated At:02:05

PARIS, Sept. 16, 2024 /PRNewswire/ -- Mugler announces the release of a documentary directed by Matthieu Menu and produced by Terminal 9 that takes the audience behind-the-scenes of key moments in the lead up to the French house's 50th anniversary including the making of the Spring/Summer 2024 runway show by Casey Cadwallader.

Since its first apparition on Earth in 1974, Mugler has become synonymous with fashion and fragrance that is fierce, fascinating, and fantastical. Rooted deeply in the entertainment industry and beloved by boundary-pushing performers such as Beyoncé, Lady Gaga, and Dua Lipa for decades, Mugler is more than a house - it's a movement, a true cultural force shaping pop culture with its unwavering commitment to empowerment and inclusivity. Mugler has long embodied the spirit of bold self-expression, continually redefining the art of trailblazing in the world of high fashion and avant-garde fragrance.

This autumn, the French fashion house prepares to enthrall with Inside the Dream: Mugler, an exclusive documentary directed by Matthieu Menu and produced by Terminal 9. 60-minutes that dive deep into the conception and realization of key Mugler events in the lead up to the house's 50th anniversary.

The cinematic journey offers an unparalleled glimpse into the creative synapses and constellations with the Mugler universe, offering an intimate audience with Fashion Creative Director Casey Cadwallader, blending unseen archive footage with runway backstage and behind-the-scenes of the iconic Angel and Alien fragrance campaigns starring Hunter Schafer and Anok Yai, respectively.

The narrative is a celebration of a visionary heritage, exploring half a century of firsts - from Manfred Thierry Mugler's revolutionary impact on fashion and discovering the gourmand olfactive family with the Angel fragrance to Casey Cadwallader's spectacular fashion presentations and cutting-edge innovations. The documentary reveals the making of Zendaya's show-stopping appearance in the chrome robot Maschinenmensch from the Fall/Winter 1995-1996 'Cirque d'hiver' collection for the premier of Dune 2, capturing the electrifying essence of Mugler's impact on the world's red carpets.

"50 years of Mugler is a testament to the power of bold creativity. With Fashion Creative Director Casey Cadwallader, the brand continues to honor Manfred Thierry Mugler's transformative legacy and shape the future of fashion and fragrance together, with its iconic designs and groundbreaking innovations." Danièle Lahana-Aidenbaum, Global Brand President Mugler Fashion & Fragrances.

Featuring iconic fashion figures associated with the house of Mugler such as Pat Cleveland, Iman Bowie, Zendaya, Paris Hilton, Law Roach, as well as key insiders such as Casey Cadwallader – Fashion Creative Director, Cyril Chapuy - L'Oréal Luxe President , Danièle Lahana-Aidenbaum - Global Brand President Mugler Fashion & Fragrances, Olivier Cresp - Master Perfumer DSM-FIRMENICH, just to name a few, and a colorful cast of creatives, the documentary captures the essence of empowerment and fierce spirit that has long defined the brand.

Inside the Dream: Mugler will be available to watch exclusively on Canal+ in France from September 25th and soon worldwide on selected platforms including Prime Video.

Oanna Lepron - Oanna.LEPRON@loreal.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

INSIDE THE DREAM: MUGLER, THE NEW DOCUMENTARY

INSIDE THE DREAM: MUGLER, THE NEW DOCUMENTARY

Recommended Articles